You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
舒泰神(300204.SZ):BDB-001注射液治療新冠肺炎臨牀試驗獲倫理委員會批准
格隆匯 02-17 08:38

格隆匯2月17日丨舒泰神(300204.SZ)公佈,公司及全資子公司德豐瑞研發的關於BDB-001注射液治療新冠肺炎的Ib期臨牀試驗已獲得樹蘭(杭州)醫院、中國人民解放軍中部戰區總醫院倫理委員會批准,完成準備工作,即將開展上述臨牀試驗。

此次BDB-001注射液的兩個適應症:(1)用於新型冠狀病毒感染者降低重症肺炎的發生率、降低急性呼吸窘迫綜合徵的發生率;(2)用於新型冠狀病毒感染所致重症肺炎的治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account